DEUTSCHE BANK AG\ - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 54 filers reported holding AGEX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,000
-83.3%
1,100
-84.3%
0.00%
Q1 2020$6,000
-50.0%
6,989
-5.9%
0.00%
Q4 2019$12,000
+20.0%
7,425
+24.5%
0.00%
Q3 2019$10,000
-82.8%
5,962
-62.8%
0.00%
Q2 2019$58,000
+31.8%
16,017
+44.9%
0.00%
Q1 2019$44,000
+18.9%
11,056
-13.6%
0.00%
Q4 2018$37,00012,7940.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$2,038,0660.18%
Beirne Wealth Consulting Services, LLC 18,000$16,0770.01%
Strategic Wealth Investment Group, LLC 92,603$62,9700.01%
Prescott General Partners LLC 185,185$125,9260.01%
Summit X, LLC 37,000$25,1600.01%
Sigma Planning Corp 181,385$123,3420.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 144,770$98,4440.00%
Piscataqua Savings Bank 1,000$6800.00%
UBS Group AG 235$1600.00%
BNP PARIBAS FINANCIAL MARKETS 74$500.00%
View complete list of AGEX THERAPEUTICS INC shareholders